申请人:HERCON LABORATORIES CORPORATION
公开号:EP0251425A1
公开(公告)日:1988-01-07
Described is an article of manufacture useful in administration of pharmacologically-active substances, transdermally, orally or by means of subdermal implant comprising a plasticized polyvinyl chloride layer for contacting a patient's tissue, internally or externally, the layer containing from about 20 up to about 70% by weight of a polyvinyl chloride resin or a polyvinyl chloride-polyvinyl acetate copolymer containing a minor proportion of vinyl acetate; from about 20-70% plasticizer composition; from about 0.5 up to 35% of a pharmacologically-active substance such as isosorbide dinitrate, nicotine, clonidine, guanfacine, indomethacin, glyceryl trinitrate and prostaglandin and optionally excipients. Also described is the novel plasticizer-polyvinyl chloride composition of matter comprising 1-dodecylhexahydro-2H-azepin-2-one and polyvinyl chloride resin taken together with a pharmacologically-active substance wherein the 1-dodecylhexahydro-2H-azepin-2-one not only acts as a plasticizer but also acts as a penetration enhancer (through tissue) for the pharmacologically-active substance.
描述了一种用于经皮、口服或通过皮下植入给药活性物质的制造品,该制造品包括用于内部或外部接触患者组织的增塑聚氯乙烯层,该层含有按重量计约20%至约70%的聚氯乙烯树脂或含有少量醋酸乙烯的聚氯乙烯-聚醋酸乙烯共聚物;约20%至70%的增塑剂组合物;约0.5% 至 35% 的药理活性物质,如二硝酸异山梨酯、尼古丁、氯尼丁、胍法辛、吲哚美辛、三硝酸甘油酯和前列腺素,以及可选的赋形剂。还描述了新型增塑剂-聚氯乙烯物质组合物,该物质组合物由 1-十二烷基六氢-2H-氮杂卓-2-酮和聚氯乙烯树脂以及药理活性物质组成,其中 1-十二烷基六氢-2H-氮杂卓-2-酮不仅用作增塑剂,还用作药理活性物质的渗透促进剂(通过组织)。